The dissociative psychedelic renaissance

Shaping the renaissance of psychedelic research.

Psychedelic drugs have a rich and vibrant history as clinical aids for psychiatry. For two decades after the discovery of lysergide (LSD) in the 1940s, psychedelics were extensively studied and clinical progress was good. But research collapsed rapidly in 1966 when LSD was made illegal, and there was a subsequent hiatus of psychedelic research. After 40 years, this pause is now coming to an end...

The Psychedelic Renaissance: Horizons, the Fifth Annual Conference on Psychedelic Research

In the spring of 1943, a 37-year-old Swiss chemist named Albert Hofmann had “a peculiar presentiment.” He believed that he had missed something in 1938, the year when he first synthesized the twenty-fifth compound of the lysergic acid diethylamide series, LSD-25. For eight years at Sandoz Pharmaceuticals, Hofmann was in charge of the ergot project, which involved synthesizing ergotamine molecul...

Psychedelic States and Schizophrenia

As long as a man can talk to himself about himself, he retains some sense of personal identity and separateness. Once he stops talking (self-reflective thinking) and begins to listen "to the song going on within him," all boundaries, internal and external, cease to exist—including the internal-external boundary itself. In some cases, this state is experienced or interpreted as psychotic death; ...

Psychotoxic or Psychedelic

Turning the Tide for Psychedelic Medicines

Psychedelic Medicine provides a broad overview of this re-emerging field in 30 chapters authored primarily by leading physicians, medical researchers, and psychologists who have continued to explore the potentials of these substances. Complemented by the legal and social views of anthropologists and lawyers, these substances and their healing potentials are re-evaluated in light of the recent d...